Significant Growth of Special Needs Plans in Medicare Advantage

Enrollment in Special Needs Plans (SNPs) within Medicare Advantage represents a substantial portion of recent growth in this sector, despite a slowdown in the broader market. According to the Kaiser Family Foundation (KFF), SNPs accounted for 83% of the enrollment increase over the past year. By February, total enrollments in SNPs exceeded 8 million, a rise of nearly 900,000 from the previous year's figures.

Medicare Advantage, a private insurance alternative to traditional Medicare, reported an overall enrollment of 35.5 million in February 2026. This reflects a 3.2% growth over the prior year, significantly lower than the 7% to 10% annual growth rates observed from 2017 to 2024. SNPs, established permanently in 2018, target dual-eligible individuals on Medicare and Medicaid, those with chronic conditions, and people requiring institutional care. These plans are lucrative for insurers due to higher per enrollee payments, which reflect the complex medical care required for their members.

The Medicare Payment Advisory Commission (MedPAC) indicates that government spending on Medicare Advantage enrollees exceeds that for traditional Medicare beneficiaries by 20%, contributing to an extra $84 billion in costs for 2025. SNPs, in particular, deliver higher profit margins than general Medicare Advantage plans. MedPAC reports dual-eligible SNPs achieved an average margin of 7.5%, while chronic-condition SNPs attained a 7.4% margin, both substantially above the average 3.6% for Medicare Advantage overall. Insurers emphasize the strategic importance of SNPs in earnings reports, continuing to spotlight their financial viability within the Medicare Advantage framework.